REDUCED SEROLOGICAL RESPONSE TO COVID-19 BOOSTER VACCINES IN PATIENTS WITH IBD IS FURTHER DIMINISHED BY TNF INHIBITOR THERAPY; VARIATION STUDY PART 2 (VARIABILITY INRESPONSEIN IBDAGAINSTSARS-COV-2IMMUNISATION)

Jayne Doherty  ¹     Neil O´Morain  ²     Roisin Stack  ²     Miriam Tosetto  ²     Rosanna Inzitari  ³     Elizabeth Ryan  ⁴     David J. Daghfal  ⁵     Peter Doran  ⁵     Colm O'Morain  ⁶     Glen A Doherty  ^6    
1 St Vincent's Hospital, Dublin, Ireland
² St. Vincent's University Hospital, Dublin, Ireland
³ University College Dublin, Dublin, Ireland
⁴ University Limerick, Limerick, Ireland
⁵ Abbott Laboratories, Lake Forest, IL, United States
⁶ Trinity College Dublin - Faculty of Health Sciences, Trinity College Dublin, Dublin/IE, Dublin

Topic
IBD, Neurogastroenterology & Motility, Nurses, Primary Care

Session
COVID-19 complications in the lower GI tract

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)